Clinical Trial Update: Brain and Gut Plasticity in Mild TBI or Post-acute COVID Syndrome Following Growth Hormone Therapy [Phase 3]

View source ↗

Summary

Phase 3 study evaluating growth hormone therapy for brain and gut plasticity in mild traumatic brain injury and post-acute COVID-19 syndrome; results have been …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• Somatropin (somatropin)

Snippet

Sponsor: The University of Texas Medical Branch, Galveston | Conditions: Traumatic Brain Injury, Fatigue | Phase 3 | Status: COMPLETED | Results posted: 2025-03-05